Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Regulatory News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ESM - Schedule One

14 May 2012 07:00

RNS Number : 2507D
Sterling Green Group PLC
14 May 2012
 



Pre-Admission AnnouncementESM Schedule 1

Announcement to be made by the ESM Applicant prior to admission in accordance withrule 2 of the ESM Rules for Companies

All Applicants must complete the following

Company name STERLING GREEN GROUP PLC TO BE RENAMED FASTNET OIL & GAS PLC (THE "COMPANY")

 

Company registered address and if different, company trading address (including postcodes)

REGISTERED OFFICE AND TRADING ADDRESS

Number 14, The Embankment

Vale Road

Heaton Mersey

Stockport,

Cheshire SK4 3GN

United Kingdom

 

TRADING ADDRESS

18 Fitzwilliam Place,

Dublin 2,

Ireland

 

Country of incorporation

England and Wales

Company website address containing all information required by rule 26 in the ESM Rulesfor Companies

http://sterlinggreen.co.uk/sgg/ to become www.fastnetoilandgas.com following admission

Company business (including main country of operation) or, in the case of an investing company, details of its investing strategy. If the admission is sought as a result of a reverse takeover under rule 14 of the ESM Rules for Companies, this should be stated

 

The Company has, since 1 December 2011, been classified as an investing company under Rule 15 of the AIM Rules for Companies ("AIM Rules"). On 14 May 2012 the Company entered into a conditional agreement to acquire the entire issued share capital of Terra Energy Limited ("Terra") for an aggregate consideration to be satisfied by the issue of 64,129,611 consideration shares and the payment of €40,000. The acquisition constitutes a reverse takeover under Rule 14 of the AIM Rules. The Company is also proposing to raise £10.0 million (before expenses) through a conditional placing of 90,909,091 new ordinary shares (following the share consolidation) to provide further working capital for the enlarged group.

 

Terra was incorporated in February 2008 and was established to explore and develop unconventional oil and gas resources in Europe and North Africa. Terra has since focused on oil and gas prospects in the Celtic Sea. In addition, Terra plans to avail itself of new potential opportunities in North and East Africa where certain of the proposed directors have significant knowledge, contacts.

 

On Admission, Terra's assets will include an interest in a net profit bonus arrangement relating to the Connemara prospects offshore Ireland ("NPB Agreement") and 13 coal licenses based in the Connaught Coal Field, onshore Ireland. Terra has also made applications to the Petroleum Affairs Division of the Department of Communications, Energy and Natural Resources of Ireland for three offshore licensing options in the Celtic Sea and an onshore licence in the Dublin Basin.

 

Details of securities to be admitted including any restrictions as to transfer of securities (i.e. where known, number of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares)

 

163,030,160 ordinary shares of 3.8p each ("Ordinary Shares")

 

 

Capital to be raised on admission (if applicable) and anticipated market capitalisation on admission

 

Placing of 90,909,091 Ordinary Shares at 11p per Ordinary Share to raise £10.0 million

 

Approximate market capitalisation of £17.93 million on Admission at the placing price

 

 

Percentage of ESM securities not in public hands on admission

 

25.85%

 

 

Details of any other exchange or trading platform to which the ex securities (or other securities of the company) are or will be admitted or traded

Application has also been made to have the shares admitted to the AIM Market of the London Stock Exchange

 

 

Full names and functions of directors and proposed directors (underlining the first name by which each is known or including any other name by which each is known)

 

Cathal Martin Friel Non-Executive Chairman

 

George Henry Stephen Staley CEO

 

Michael Henry Nolan Non-Executive Director

 

John Michael Edelson Non-Executive Director

 

 

Full names and holdings of significant shareholders, expressed as a percentage of the issued share capital, before or after admission (underlining the first name by which each is known or including any other name by which each is known)

 

Currently

On Admission

Name

Number of Ordinary Shares held

Percentage of issued share capital

Number of Ordinary Shares held

Percentage of issued share capital

Cathal Friel1

0

0

18,888,051

11.59%

Henderson Global Investors Limited

0

0

8,181,818

5.02%

CQS Asset Management Limited

0

0

7,500,000

4.60%

Davycrest Nominees

0

0

7,136,363

4.38%

Mandatum Life Insurance Company Limited

0

0

6,954,545

4.27%

Standard Life Investments Limited

0

0

6,818,182

4.18%

BlackRock Investment Management (UK) Limited

0

0

5,000,000

3.07%

M Edelson2

35,050,390

11.54

922,384

0.57%

Selwyn Lewis

29,687,500

9.78

781,250

0.48%

Rock Nominees Limited

29,687,500

9.78

781,250

0.48%

BK Charitable Trust

15,500,000

5.10

407,894

0.25%

Pentagon Dollar Satellite Fund Limited

15,000,000

4.94

394,736

0.24%

HSBC Global Custody Nominees

15,000,000

4.94

394,736

0.24%

I Aspinall3

12,250,000

4.03

322,368

0.20%

J H Lyons

12,000,000

3.95

315,789

0.19%

JIM Nominees Limited

10,308,960

3.39

271,288

0.17%

 

Notes:

1. Cathal Friel's interest in new ordinary shares in the Company will include 15,554,857 new ordinary shares held by Raglan Road Capital Limited, a Company in which Cathal Friel and his wife, Pamela Iyer, have a 90 per cent. interest.

2. Michael Edelson's interest in existing ordinary shares in the Company include 1,000,000 shares held by his wife, JB Edelson, 1,750,000 shares held by Novabank Capital Limited and 3,800,390 shares held by London and City Credit Corporation Limited. In addition, Michael Edelson holds 1,000,000 existing ordinary shares non-beneficially as a trustee of The Morris Edelson Settlement.

3. Ian Aspinall has non-beneficial interests in existing ordinary shares in the Company, being 8,250,000 shares held non-beneficially as a trustee of The Blueberry Charitable Trust and 4,000,000 shares held non-beneficially by his wife, J M Aspinall, as a trustee of The Cheshire Children's Charitable Trust.

Names of all persons to be disclosed in accordance with schedule two, paragraph (h) of the ESM Rules for Companies

N/A

i anticipated accounting reference date

31 March

ii date to which the main financial information in the admission document has been prepared

31 March 2012

iii dates by which it must publish its first three reports pursuant to Rules 18 and 19 in the ESM Rules for Companies

As follows:

a. 6 months ended 30 September 2012 by 31 December 2012;

b. Year ending 31 March 2013 by 30 September 2013; and

c. 6 months ended 30 September 2013 by 31 December 2013;

 

 

 

Expected admission date

11 June 2012

Name and address of ESM Adviser

Davy, Davy House, 49 Dawson Street, Dublin 2, Ireland.

Name and address of broker

 Davy

Davy House

49 Dawson Street

Dublin 2, Ireland

 

Shore Capital Stockbrokers Limited

Bond Street House

14 Clifford Street

London W1S 4JU

Other than in the case of a quoted Applicant, details of where (postal or internet address) the admission document will be available from, with a statement that this will contain full details about the Applicant and the admission of its securities

 

Copies of the admission document will be available to the public, free of charge, at the registered office of the Company at Number 14 The Embankment, Vale Road, Heaton Mersey, Stockport SK4 3GN, telephone 0161 975 0434 during normal business hours on any weekday (Saturdays and public holidays excepted) for a period of one month from the date of Admission. This document is also available free of charge for such period on the Company's website at http://sterlinggreen.co.uk/sgg/

 

Date of notification

14 May 2012

New/update (see note):

NEW

Quoted Applicants must also complete the following

The name of the ESM designated market upon which the Applicant's securities have been traded

The date from which the Applicant's securities have been so traded

 

Confirmation that, following due and careful enquiry, the Applicant has adhered to any legal and regulatory requirements involved in having its securities traded upon such a market or details of where there has been any breach

An address or web-site address where any documents or announcements which the Applicant has made public over the last two years (in consequence of having its securities so traded) are available

 

Details of the Applicant's strategy following admission including, in the case of an investing company, details of its investment strategy

A description of any significant change in financial or trading position of the Applicant, which has occurred since the end of the last financial period for which audited statements have been published

A statement that the directors of the Applicant have no reason to believe that the working capital available to it or its group will be insufficient for at least twelve months from the date of its admission

Details of any lock-in arrangements pursuant to rule 7 of the ESM Rules for Companies

A brief description of the arrangements for settling the Applicant's securities

A website address detailing the rights attaching to the Applicant's securities

Information equivalent to that required for an admission document which is not currently public

A website address of a page containing the Applicant's latest annual report and accounts which must have a financial year end not more then nine months prior to admission and fully audited interim results where applicable. The accounts must be prepared according to Irish, UK or USGAAP or international accounting standards.

The number of each class of securities held in treasury

Note: this field should indicate that the announcement is 'new' and all relevant fields should be completed. Otherwise where the form is required to be completed in respect of an 'update' announcement, this should be indicated. In such cases, all the original information should be included with any amended fields emboldened.

Submit completed form for market dissemination to announcements@ise.ie

 

This announcement has been issued through the Companies Announcement Service of

the Irish Stock Exchange.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEGGUWCAUPPUAC
Date   Source Headline
24th Apr 20177:00 amRNSFirst Patient Enrolled
10th Apr 20175:21 pmRNSDirector/PDMR Shareholding
6th Apr 20174:13 pmRNSPosting of Annual Report 2016 and Notice of AGM
30th Mar 20177:00 amRNSFinal Results
28th Mar 20177:00 amRNSPhase 3 Clinical Trial for AP101 commenced
27th Mar 20177:00 amRNSSenior Management Appointment
8th Mar 20177:00 amRNSNotice of Results
6th Mar 20177:00 amRNSAP101 trial discussions completed with FDA & EMA
9th Feb 20177:00 amRNSDirectorate Change
7th Feb 20177:00 amRNSGrant of patent in Japan for AP101 (Episalvan)
6th Feb 20177:00 amRNSPre-clinical study results
5th Dec 20167:00 amRNSTransformational Licence Agreement
2nd Dec 20167:00 amRNSEUR20m Facility with European Investment Bank
7th Nov 20167:00 amRNSOrphan drug designation for Acromegaly Compound
19th Sep 20167:00 amRNSAppointment of Chief Medical Officer
13th Sep 20167:00 amRNSGrant of US patent for lead drug, Episalvan
13th Sep 20167:00 amRNSHalf-year Report
7th Jul 201612:54 pmRNSResult of AGM
27th Jun 20167:00 amRNSMarkus Ziener appointed as Non-Executive Director
9th Jun 20167:00 amRNSFinancial Results
2nd Jun 20164:34 pmRNSNotice of Results
21st Apr 20164:35 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSAdmission to trading on AIM and ESM
18th Apr 20162:30 pmRNSESM Schedule 1 Update
18th Apr 20162:30 pmRNSSchedule One update - Fastnet Equity plc
18th Apr 201612:41 pmRNSResult of General Meeting and Change of Name
31st Mar 20167:35 amRNSESM Schedule 1
31st Mar 20167:30 amRNSSchedule One - Fastnet Equity plc
31st Mar 20167:30 amRNSRestoration - Fastnet Equity plc
31st Mar 20167:00 amRNSProposed Acquisition of Amryt Pharmaceuticals
22nd Feb 20167:30 amRNSSuspension - Fastnet Equity plc
22nd Feb 20167:30 amRNSPotential Acquisition and Statement re Suspension
21st Dec 20157:01 amRNSAppointment of Non-executive Director
21st Dec 20157:00 amRNSInterim Results
18th Dec 20157:00 amRNSDemerger of Oil and Gas Assets
30th Sep 20153:12 pmRNSResult of Annual General Meeting
4th Sep 20157:00 amRNSFinal Results
28th Aug 20153:31 pmRNSResult of General Meeting
11th Aug 20153:35 pmRNSProposed adoption of Investing Policy/Notice of GM
3rd Jul 20153:22 pmRNSDirector/PDMR Shareholding
26th Jun 20152:45 pmRNSDirector/PDMR Shareholding
2nd Jun 20152:27 pmRNSHolding(s) in Company
1st Jun 20157:00 amRNSCorporate Update
26th Mar 20157:00 amRNSCeltic Sea Portfolio
27th Jan 201512:56 pmRNSDirectorate Change
9th Jan 201512:49 pmRNSHolding(s) in Company
2nd Jan 20157:00 amRNSExpiry of Tendrara Option Agreement
19th Dec 20147:00 amRNSInterim Results
10th Dec 20147:00 amRNSBoard changes & operational update
1st Dec 20143:00 pmRNSResponse to press speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.